In April 2026, BioSpace senior editor Annalee Armstrong visited Nusano’s 190,000-square-foot production facility in West Valley City, Utah for an inside look at the company’s linear accelerator-based production platform.
At the time of her visit, final assembly of the platform was underway. Armstrong toured the production floor, met team members supporting the work, and followed the path accelerated particles will take to one of 12 target bays where radioisotopes will be produced.
Now, in an article published by BioSpace, Armstrong shares her impressions from the visit:
A few years ago, Big Pharma began rushing into radiopharma. But it turns out, no one considered whether the existing manufacturing infrastructure could handle the load of new radioligand therapies that would one day need to reach patients—and quickly.
Enter Nusano, the Salt Lake City–based physics company developing a brand-new radioisotope facility.
…Nusano’s collective brain power includes experts from every high-scale nuclear facility in the world, from submarines to famed particle accelerators to power plants.
…I have been a particle accelerator geek since I was 19 years old,” [Nusano senior director Elvin] Harms said.
But he was lured over to Nusano with the promise of contributing to Nusano’s oncology mission. “This is too important,” he said.
Armstrong was in Utah as part of BioHive Week, an annual celebration of Utah’s life sciences community organized by the trade association BioHive.
Nusano appreciates Armstrong’s visit and BioHive’s support in coordinating the tour during BioHive Week.
You can read Armstrong’s full article and view photos from inside Nusano’s production facility at BioSpace.com.
Posted May 27, 2026
